SWM
AVXL icon

Spire Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Spire Wealth Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.85K Hold
2,645
– – ﹤0.01% 1754
2026
Q1 		$8.12K Hold
2,645
– – ﹤0.01% 1691
2025
Q4 		$9.42K Hold
2,645
– – ﹤0.01% 1721
2025
Q3 		$23.5K Hold
2,645
– – ﹤0.01% 1477
2025
Q2 		$24.4K Hold
2,645
– – ﹤0.01% 1444
2025
Q1 		$22.7K Hold
2,645
– – ﹤0.01% 1568
2024
Q4 		$28.4K Hold
2,645
– – ﹤0.01% 1499
2024
Q3 		$15K Hold
2,645
– – ﹤0.01% 1525
2024
Q2 		$11.2K Hold
2,645
– – ﹤0.01% 1609
2024
Q1 		$13.5K Hold
2,645
– – ﹤0.01% 1627
2023
Q4 		$16K Hold
2,645
– – ﹤0.01% 1605
2023
Q3 		$17.3K Hold
2,645
– – ﹤0.01% 1557
2023
Q2 		$21.5K Hold
2,645
– – ﹤0.01% 1569
2023
Q1 		$22.7K Hold
2,645
– – ﹤0.01% 1573
2022
Q4 		$24K Hold
2,645
– – ﹤0.01% 1293
2022
Q3 		$27K Hold
2,645
– – ﹤0.01% 1199
2022
Q2 		$26K Hold
2,645
– – ﹤0.01% 1551
2022
Q1 		$33K Hold
2,645
– – ﹤0.01% 1609
2021
Q4 		$46K Sell
2,645
-150
-5% -$2.85K ﹤0.01% 1772
2021
Q3 		$50K Buy
2,795
+150
+6% +$2.99K ﹤0.01% 1472
2021
Q2 		$60K Sell
2,645
-325
-11% -$4.81K ﹤0.01% 1401
2021
Q1 		$44K Buy
+2,970
New +$32.4K ﹤0.01% 1782

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Spire Wealth Management's AVXL Position: Q2 2026 in Review

Spire Wealth Management held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 2,645 shares worth $6.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

Spire Wealth Management first reported a position in AVXL in Q1 2021 and has held it in 22 quarters since. The position peaked at $60K in Q2 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Spire Wealth Management held 2,645 shares of Anavex Life Sciences worth $6.85K as of Q2 2026.
  • Spire Wealth Management left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1754 holding.
  • Spire Wealth Management first reported a position in Anavex Life Sciences in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Anavex Life Sciences position peaked at $60K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.